MEDVi vs TMates: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
TMates beats MEDVi overall, scoring 7.8/10 vs 7.7/10. TMates is more affordable at $199/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose TMates for users with insurance who want a coached glp-1 program with m.
A side-by-side comparison of MEDVi and TMates covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViTMates
#15 of 40Insurance-friendly compounded GLP-1 program with coaching support and multiple medication options.
Visit TMates| Feature | MEDVi | TMates |
|---|---|---|
| Our Score | 7.7/10 | 7.8/10 |
| Starting Price | $299/mo | $199/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | Yes |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users with insurance who want a coached GLP-1 program with multiple medication options |
| Ranking | #21 | #15 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
TMates
Pros
- +Accepts major insurance (Aetna, Cigna, UnitedHealthcare, BCBS) — one of the few compounded GLP-1 providers to do so
- +100% no-questions-asked refund policy — contact support for a full refund if unsatisfied
- +24/7 support with health coaching, nutrition guidance, and progress tracking included
- +Available in all 50 states plus Puerto Rico and territories
Cons
- −90-second assessment quiz suggests convenience over clinical thoroughness compared to competitors with full medical intakes
- −Insurance coverage for compounded medications varies significantly — verify coverage before enrolling
- −Heavy press-release marketing and limited independent reviews make it hard to verify claims
Our Verdict
TMates edges out MEDVi with a score of 7.8/10 vs 7.7/10. If budget is your priority, TMates starts at $199/mo compared to MEDVi's $299/mo. TMates accepts insurance, which can significantly reduce your out-of-pocket costs. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose TMates if you want: users with insurance who want a coached glp-1 program with multiple medication options.